Bank of Nova Scotia filings document the regulatory disclosures of a Canadian bank and foreign private issuer whose securities trade on the TSX and NYSE under BNS. Its Form 6-K reports include earnings-related releases, capitalization and earnings-ratio exhibits, Canadian certification materials, and updates incorporated by reference into Form F-3 and Form S-8 registration statements.
The bank’s filings also record governance and shareholder matters, including proxy circular materials, board mandates, by-law amendments, annual and special meeting voting results, and director-election outcomes. Capital-structure disclosures cover common shares, preferred shares and other equity instruments, subordinated indebtedness, normal course issuer bids, and other regulatory capital matters.
The Bank of Nova Scotia is offering senior unsecured Contingent Income Auto-Callable Securities maturing around December 10, 2029, linked to the common stock of NVIDIA Corporation. These notes are principal-at-risk and pay a contingent quarterly coupon of $27.80 per $1,000 (11.12% per year) only if NVIDIA’s closing price on the relevant determination date is at least 55% of the initial share price. Missed coupons can be paid later under a memory feature if this condition is later met.
The notes are automatically called if, on any non-final determination date, NVIDIA’s closing price is at or above 100% of the initial share price, returning principal plus the due coupon and any unpaid coupons, after which no further payments are made. If held to maturity and the final share price is below 55% of the initial level, investors receive the principal multiplied by the share performance factor, exposing them 1-for-1 to downside and potentially losing their entire investment. The notes are not listed, have limited liquidity, carry BNS credit risk, and have an initial estimated value between $932.71 and $962.71 per $1,000, below the issue price.
Bank of Nova Scotia details several major balance sheet and capital actions. The bank completed the sale of its banking operations in Colombia, Costa Rica and Panama to Davivienda, and in connection with this exit recorded a goodwill write-down of $589 million pre-tax within its Latin America and Caribbean & Central America cash-generating units, along with an additional impairment loss of $165 million pre-tax. Earlier, in fiscal 2024, it had recorded a goodwill write-down of $92 million pre-tax tied to the planned sale of CrediScotia Financiera in Peru.
The bank continued to manage its capital structure using Limited Recourse Capital Notes (LRCNs). It issued USD$1,000 million of 7.350% LRCN Series 6 with matching Additional Tier 1 (AT1) Notes in January 2025 and USD$1,000 million of 6.875% LRCN Series 7 with related AT1 Notes in September 2025, while redeeming US $1,250 million of 4.900% AT1 Notes, which generated a foreign currency loss of $22 million recorded in retained earnings.
The bank also expanded its strategic investments, lifting its KeyCorp stake to 14.9% and recognizing dividends of $140 from this associate, and it reports a market value of $4,018 for this holding and $617 for its investment in Bank of Xi’an based on quoted exchange prices.
The Bank of Nova Scotia filed a Form 6-K as a foreign private issuer to furnish its 2025 Annual Report, which is attached as Exhibit 99.1. The filing states that this Form 6-K is incorporated by reference into the bank’s existing registration statements on Form S-8 and Form F-3, making the annual report part of those securities offering documents from the filing date.
The Bank of Nova Scotia has furnished a Form 6-K that makes its 2025 Annual Financial Statements and 2025 Management’s Discussion and Analysis available as exhibits. These documents provide detailed information on the bank’s annual financial performance and management’s commentary on its operations and risks.
The filing also states that this report is incorporated by reference into the bank’s existing registration statements on Form S-8 and Form F-3, meaning those offerings now legally include the latest annual financial and MD&A information.